Introduction
In this episode of Oye.Cracks, we interview Dr. Rafael Guevara Corona, the Medical Director for Latin America at Bausch Health Companies. Together with Dr. Guevara, we discuss a critical yet underrecognized topic: the Cardiorenal Metabolic Syndrome (SCRM). We explore why SCRM has become one of the leading silent threats to health, the factors driving its growing prevalence in Mexico, and the latest therapeutic alternatives developed by Laboratorios Grossman and Bausch Health, such as their Cardiometabolic Line, focused on effective and sustainable control.
Who is Dr. Rafael Guevara Corona?
Dr. Rafael Guevara Corona is a renowned medical professional and the Medical Director for Latin America at Bausch Health Companies. With extensive experience in the healthcare sector, Dr. Guevara Corona is well-positioned to address pressing health issues affecting the Latin American population.
What is Cardiorenal Metabolic Syndrome (SCRM)?
Cardiorenal Metabolic Syndrome (SCRM) is a complex interplay of cardiovascular, renal, and metabolic disorders. It is characterized by conditions such as hypertension, diabetes, chronic kidney disease, and obesity. SCRM poses a significant risk to overall health, as it can lead to heart failure, stroke, and end-stage renal disease.
Why is SCRM a growing concern in Mexico?
Several factors contribute to the rising prevalence of SCRM in Mexico. These include:
- High rates of obesity and overweight individuals
- Increasing prevalence of type 2 diabetes
- High consumption of salt, leading to hypertension
- Limited access to quality healthcare in some regions
Latest Therapeutic Alternatives by Bausch Health and Laboratorios Grossman
Bausch Health and Laboratorios Grossman have developed a Cardiometabolic Line of products aimed at effectively managing SCRM. These therapeutic alternatives focus on:
- Blood pressure control
- Glycemic management for diabetes
- Lipid management to reduce cardiovascular risk
- Kidney protection and function support
Key Questions and Answers
- What is the Cardiorenal Metabolic Syndrome (SCRM)?
SCRM is a combination of cardiovascular, renal, and metabolic disorders that can lead to severe health complications if left unmanaged. - Why is SCRM a growing concern in Mexico?
SCRM’s rising prevalence in Mexico can be attributed to high obesity rates, increasing diabetes cases, salt consumption, and limited healthcare access in certain regions. - What are the latest therapeutic alternatives for SCRM?
Bausch Health and Laboratorios Grossman have developed a Cardiometabolic Line, which includes products for blood pressure control, glycemic management, lipid management, and kidney protection.
Join us in raising awareness about SCRM and promoting a real change towards health prevention and comprehensive care. Subscribe to our channel and follow along in this crucial conversation for the health of Mexicans.
